Insider · CIK 0001568249

Rhodes Jennifer J

Reports to the SEC for 4 companies · SAN DIEGO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001568249

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-03-25	ACADACADIA PHARMACEUTICALS INCS Sale	EVP, CHIEF LEGAL OFFICER, SEC	SSale	−3,844 sh	$21.47	−$82.5K	11,280
2026-03-24	ACADACADIA PHARMACEUTICALS INCM Exercise/Conversion	EVP, CHIEF LEGAL OFFICER, SEC	MExercise/Conversion	+7,515 sh	—	—	15,124
2026-03-24	ACADACADIA PHARMACEUTICALS INC · Restricted Stock UnitsM Exercise/Conversion	EVP, CHIEF LEGAL OFFICER, SEC	MExercise/Conversion	−7,515 sh	—	—	22,547
2026-03-06	ACADACADIA PHARMACEUTICALS INC · Stock Option (Right to Buy)A Award	EVP, CHIEF LEGAL OFFICER, SEC	AAward	+90.7K sh	—	—	90,691
2026-03-06	ACADACADIA PHARMACEUTICALS INC · Restricted Stock UnitsA Award	EVP, CHIEF LEGAL OFFICER, SEC	AAward	+26.4K sh	—	—	26,382
2026-02-09	ACADACADIA PHARMACEUTICALS INCS Sale	EVP, CHIEF LEGAL OFFICER, SEC	SSale	−6,950 sh	$23.38	−$162K	7,609
2026-02-06	ACADACADIA PHARMACEUTICALS INCM Exercise/Conversion	EVP, CHIEF LEGAL OFFICER, SEC	MExercise/Conversion	+12.9K sh	—	—	14,559
2026-02-06	ACADACADIA PHARMACEUTICALS INC · Restricted Stock UnitsM Exercise/Conversion	EVP, CHIEF LEGAL OFFICER, SEC	MExercise/Conversion	−12.9K sh	—	—	12,945
2025-03-24	ACADACADIA PHARMACEUTICALS INC · Stock Option (Right to Buy)A Award	EVP, CHIEF LEGAL OFFICER, SEC	AAward	+102K sh	—	—	102,289
2025-03-24	ACADACADIA PHARMACEUTICALS INC · Restricted Stock UnitsA Award	EVP, CHIEF LEGAL OFFICER, SEC	AAward	+30.1K sh	—	—	30,062
2024-02-06	ACADACADIA PHARMACEUTICALS INC · Stock Option (Right to Buy)A Award	EVP, CHIEF LEGAL OFFICER, SEC	AAward	+127K sh	—	—	126,589
2024-02-06	ACADACADIA PHARMACEUTICALS INC · Restricted Stock UnitsA Award	EVP, CHIEF LEGAL OFFICER, SEC	AAward	+25.9K sh	—	—	25,889
2022-03-02	ELTXElicio Therapeutics, Inc. · Stock Option (Right to Buy)A Award	See Remarks	AAward	+175K sh	—	—	175,000
2022-03-02	ELTXElicio Therapeutics, Inc. · Stock Option (Right to Buy)A Award	See Remarks	AAward	+100K sh	—	—	275,000
2021-12-14	ELTXElicio Therapeutics, Inc.S Sale	See Remarks	SSale	−451 sh	$2.42	−$1,090.112	30,399
2021-11-15	ELTXElicio Therapeutics, Inc.S Sale	See Remarks	SSale	−433 sh	$4.40	−$1,905.2	30,850
2021-10-14	ELTXElicio Therapeutics, Inc.S Sale	See Remarks	SSale	−430 sh	$8.65	−$3,719.5	31,283
2021-09-14	ELTXElicio Therapeutics, Inc.S Sale	See Remarks	SSale	−430 sh	$10.64	−$4,575.2	31,713
2021-08-16	ELTXElicio Therapeutics, Inc.S Sale	See Remarks	SSale	−445 sh	$10.68	−$4,752.6	32,143
2021-07-21	ELTXElicio Therapeutics, Inc.S Sale	See Remarks	SSale	−432 sh	$10.94	−$4,726.08	32,588
2021-07-14	ELTXElicio Therapeutics, Inc.S Sale	See Remarks	SSale	−431 sh	$11.01	−$4,745.31	32,589
2021-06-14	ELTXElicio Therapeutics, Inc.S Sale	See Remarks	SSale	−427 sh	$13.27	−$5,666.29	33,020
2021-05-14	ELTXElicio Therapeutics, Inc.S Sale	See Remarks	SSale	−440 sh	$13.92	−$6,124.8	33,447
2021-04-15	ELTXElicio Therapeutics, Inc.S Sale	See Remarks	SSale	−399 sh	$15.01	−$5,988.99	33,887
2021-03-13	ELTXElicio Therapeutics, Inc.S Sale	See Remarks	SSale	−499 sh	$20.45	−$10.2K	34,286
2021-02-13	ELTXElicio Therapeutics, Inc.S Sale	See Remarks	SSale	−457 sh	$19.54	−$8,929.78	34,785
2021-02-04	ELTXElicio Therapeutics, Inc. · Stock Option (Right to Buy)A Award	See Remarks	AAward	+70K sh	—	—	70,012
2019-06-20	Adamas Pharmaceuticals IncS Sale	CBO, GC & Compliance Officer	SSale	−940 sh	$5.35	−$5,029	63,114
2019-04-08	Adamas Pharmaceuticals IncA Award	CBO, GC & Compliance Officer	AAward	+30K sh	—	—	61,612
2019-04-08	Adamas Pharmaceuticals IncStock Option (Right to Buy)A Award	CBO, GC & Compliance Officer	AAward	+60K sh	—	—	60,000
2019-03-20	Adamas Pharmaceuticals IncS Sale	CBO, GC & Compliance Officer	SSale	−1,792 sh	$7.99	−$14.3K	31,612
2018-12-20	Adamas Pharmaceuticals IncS Sale	CBO, GC & Compliance Officer	SSale	−425 sh	$7.52	−$3,196	33,404
2018-06-21	Adamas Pharmaceuticals IncS Sale	CBO, GC & Compliance Officer	SSale	−1,002 sh	$25.48	−$25.5K	33,794
2018-03-21	Adamas Pharmaceuticals IncS Sale	CBO, GC & Compliance Officer	SSale	−982 sh	$25.89	−$25.4K	34,128
2018-03-06	Adamas Pharmaceuticals IncA Award	CBO, GC & Compliance Officer	AAward	+6,250 sh	—	—	35,110
2018-03-06	Adamas Pharmaceuticals IncStock Option (Right to Buy)A Award	CBO, GC & Compliance Officer	AAward	+37.5K sh	—	—	37,500
2017-12-21	Adamas Pharmaceuticals IncS Sale	CBO, GC & Compliance Officer	SSale	−440 sh	$32.30	−$14.2K	28,860
2017-06-21	Adamas Pharmaceuticals IncS Sale	CBO, GC & Compliance Officer	SSale	−1,041 sh	$17.53	−$18.3K	28,455
2017-01-18	Adamas Pharmaceuticals IncA Award	CBO, GC & Compliance Officer	AAward	+11.3K sh	—	—	27,187
2017-01-18	Adamas Pharmaceuticals IncStock Option (Right to Buy)A Award	CBO, GC & Compliance Officer	AAward	+67.5K sh	—	—	67,500
2016-11-07	Adamas Pharmaceuticals IncA Award	CBO, GC & Compliance Officer	AAward	+4,687 sh	—	—	15,937
2016-11-07	Adamas Pharmaceuticals IncStock Option (Right to Buy)A Award	CBO, GC & Compliance Officer	AAward	+28.1K sh	—	—	28,125
2016-05-06	Adamas Pharmaceuticals IncA Award	CBO, GC & Compliance Officer	AAward	+11.3K sh	—	—	11,250
2016-05-06	Adamas Pharmaceuticals IncStock Option (Right to Buy)A Award	CBO, GC & Compliance Officer	AAward	+67.5K sh	—	—	67,500
2015-03-16	MEDIVATION, INC.S Sale	GC & Corporate Secretary	SSale	−1,390 sh	$130.92	−$182K	11,090
2015-03-02	MEDIVATION, INC.M Exercise/Conversion	GC & Corporate Secretary	MExercise/Conversion	+2,000 sh	$47.48	+$95K	14,480
2015-03-02	MEDIVATION, INC.S Sale	GC & Corporate Secretary	SSale	−2,000 sh	$122.00	−$244K	12,480
2015-03-02	MEDIVATION, INC.Stock Option (Right to Buy)M Exercise/Conversion	GC & Corporate Secretary	MExercise/Conversion	−2,000 sh	—	—	38,000
2015-02-26	MEDIVATION, INC.M Exercise/Conversion	GC & Corporate Secretary	MExercise/Conversion	+2,000 sh	$47.48	+$95K	14,480
2015-02-26	MEDIVATION, INC.S Sale	GC & Corporate Secretary	SSale	−1,089 sh	$118.00	−$129K	13,391

Recent filings

Accepted (ET)
Mar 264
Rhodes Jennifer J0001568249-26-000005
SEC(opens sec.gov)
Mar 104
Rhodes Jennifer J0001568249-26-000004
SEC(opens sec.gov)
Feb 104
Rhodes Jennifer J0001568249-26-000002
SEC(opens sec.gov)
Mar 264
Rhodes Jennifer J0001415889-25-009073
SEC(opens sec.gov)
Feb 84
Rhodes Jennifer J0001415889-24-003039
SEC(opens sec.gov)
Mar 44
Rhodes Jennifer J0001601485-22-000012
SEC(opens sec.gov)
Dec 154
Rhodes Jennifer J0001601485-21-000083
SEC(opens sec.gov)
Nov 164
Rhodes Jennifer J0001601485-21-000072
SEC(opens sec.gov)
Oct 154
Rhodes Jennifer J0001601485-21-000060
SEC(opens sec.gov)
Sep 154
Rhodes Jennifer J0001601485-21-000056
SEC(opens sec.gov)
Aug 174
Rhodes Jennifer J0001601485-21-000050
SEC(opens sec.gov)
Jul 224
Rhodes Jennifer J0001601485-21-000040
SEC(opens sec.gov)

Companies

Address

C/O ACADIA PHARMACEUTICALS INC. 12830 EL CAMINO REAL, SUITE 400

SAN DIEGO, CA, 92130